ZIRAQUIN Trademark

Trademark Overview

On Monday, August 8, 2005, a trademark application was filed for ZIRAQUIN with the United States Patent and Trademark Office. The USPTO has given the ZIRAQUIN trademark a serial number of 78687953. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 25, 2010. This trademark is owned by SCHERING CORPORATION. The ZIRAQUIN trademark is filed in the Pharmaceutical Products category with the following description:

ANTI-INFECTIVE PREPARATIONS ONLY FOR HUMAN USE; BROAD SPECTRUM PHARMACEUTICAL PREPARATIONS ONLY FOR HUMAN USE FOR THE TREATMENT OF VIRAL DISEASES AND IMMUNOSUPPRESIVE DISORDERS
ziraquin

General Information

Serial Number78687953
Word MarkZIRAQUIN
Filing DateMonday, August 8, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 25, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2006

Trademark Statements

Goods and ServicesANTI-INFECTIVE PREPARATIONS ONLY FOR HUMAN USE; BROAD SPECTRUM PHARMACEUTICAL PREPARATIONS ONLY FOR HUMAN USE FOR THE TREATMENT OF VIRAL DISEASES AND IMMUNOSUPPRESIVE DISORDERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 15, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSCHERING CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKENILWORTH, NJ 07033
Party NameSCHERING CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKENILWORTH, NJ 070330530

Trademark Events

Event DateEvent Description
Monday, January 25, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 25, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 16, 2009EXTENSION 5 GRANTED
Monday, June 15, 2009EXTENSION 5 FILED
Monday, June 15, 2009TEAS EXTENSION RECEIVED
Tuesday, January 6, 2009EXTENSION 4 GRANTED
Wednesday, December 17, 2008EXTENSION 4 FILED
Tuesday, January 6, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 17, 2008TEAS EXTENSION RECEIVED
Wednesday, July 2, 2008EXTENSION 3 GRANTED
Thursday, June 19, 2008EXTENSION 3 FILED
Thursday, June 19, 2008TEAS EXTENSION RECEIVED
Friday, January 4, 2008EXTENSION 2 GRANTED
Friday, December 7, 2007EXTENSION 2 FILED
Friday, December 7, 2007TEAS EXTENSION RECEIVED
Thursday, August 30, 2007EXTENSION 1 GRANTED
Monday, June 11, 2007EXTENSION 1 FILED
Monday, June 11, 2007TEAS EXTENSION RECEIVED
Tuesday, December 26, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2006NOTICE OF PUBLICATION
Wednesday, August 16, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 11, 2006ASSIGNED TO LIE
Tuesday, August 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2006EXAMINERS AMENDMENT MAILED
Tuesday, August 1, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, August 1, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, July 27, 2006NON-FINAL ACTION MAILED
Thursday, July 27, 2006NON-FINAL ACTION WRITTEN
Wednesday, July 26, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, June 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2006PAPER RECEIVED
Thursday, February 23, 2006NON-FINAL ACTION MAILED
Thursday, February 23, 2006NON-FINAL ACTION WRITTEN
Thursday, February 23, 2006ASSIGNED TO EXAMINER
Monday, August 15, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

ziraquin human preparations only viral diseases immunosuppresive disorders treatment spectrum infective